India Exchange Filings

Morepen U.S. Prescription Generics Launch

Morepen Laboratories Ltd launches its first U.S. prescription generic, Desloratadine Tablets USP 5 mg

  • Morepen Bio Inc., its wholly owned U.S. subsidiary, is marketing the tablets in 100-count and 500-count packs.
  • The launch extends the company’s U.S. business from APIs into finished-dose medicines and distribution.
  • Its first U.S. FDA ANDA, for Sitagliptin tablets in three strengths, remains under regulatory review.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.